Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A1 | Q13285 | 1/20 | 0.61 |
| ▸ | LTA4H | P09960 | 4/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | PLA2G4B | P0C869 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | RARB | P10826 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL948700 | 1.00 | NR5A1 (0.61) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL2832393 | 1.00 | NR5A1 (0.61) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL3924421 | 1.00 | NR5A1 (0.61) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL9706419 | 1.00 | NR5A1 (0.61) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL4748828 | 1.00 | NR5A1 (0.61) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL949228 | 0.98 | NR5A1 (0.58) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL7697232 | 0.95 | RARB (0.58) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL10987211 | 0.95 | RARB (0.58) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL1007565 | 0.94 | LTA4H (0.53) | NR5A1LTA4HTP53TSHRNPC1 | |
| SCHEMBL10987443 | 0.93 | CYP2D6 (0.56) | NR5A1LTA4HTP53TSHRPLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4371982-A2 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX Pharmaceuticals, Inc. (US) | 2024-05-22 | — | — | EP | disclosed |
| EP-3583096-B1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS INC (US) | 2024-03-27 | — | — | EP | disclosed |
| CN-115215720-B | Graphene nano fragment molecule containing azulene unit-azulene and jade red province and synthesis method and application thereof | 中国科学院化学研究所 | 2023-08-22 | — | — | CN | disclosed |
| US-20230133667-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS INC (US) | 2023-05-04 | — | — | US | disclosed |
| US-20230133667-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS INC (US) | 2023-05-04 | — | — | US | disclosed |
| US-20230133667-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS INC (US) | 2023-05-04 | — | — | US | disclosed |
| CN-110520413-B | Macrocyclic broad spectrum antibiotics | 阿奇克斯制药公司 | 2023-02-17 | — | — | CN | disclosed |
| CN-115215720-A | Graphene nano fragment molecule-azulene jade red province containing azulene unit, and synthesis method and application thereof | 中国科学院化学研究所 | 2022-10-21 | — | — | CN | disclosed |
| CN-112275322-B | Preparation method and application of supported CNTs @ NHC-Cu catalytic material | 中国科学院兰州化学物理研究所 | 2022-01-25 | — | — | CN | disclosed |
| US-20210198316-A9 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED (GB) | 2021-07-01 | — | — | US | disclosed |
| US-7820631-B2 | Anti-viral pyrimidine nucleoside analogues | REGA FOUNDATION (BE) | 2010-10-26 | — | — | US | disclosed |
| US-7786235-B2 | Block polymer and device | CANON KABUSHIKI KAISHA (JP) | 2010-08-31 | — | — | US | disclosed |
| EP-2189482-A1 | BLOCK POLYMER AND DEVICE | Canon Kabushiki Kaisha (JP) | 2010-05-26 | — | — | EP | disclosed |
| US-20090159856-A1 | BLOCK POLYMER AND DEVICE | CANON KABUSHIKI KAISHA (JP) | 2009-06-25 | — | — | US | disclosed |
| US-20080220258-A1 | HELICAL SUBSTITUTED POLYACETYLENE STRUCTURE, METHOD FOR PRODUCING THE SAME, DEVICE STRUCTURE, ION TRANSPORT FILM AND GAS SEPARATION FILM | CANON KABUSHIKI KAISHA (JP) | 2008-09-11 | — | — | US | disclosed |
| EP-1274713-B1 | ANTI-VIRAL PYRIMIDINE NUCLEOSIDE ANALOGUES | UNIV CARDIFF (GB) | 2004-03-10 | — | — | EP | disclosed |
| US-20030148967-A1 | Anti-viral pyrimidine nucleoside analogues | REGA FOUNDATION (BE) | 2003-08-07 | — | — | US | disclosed |
| EP-1274713-A1 | ANTI-VIRAL PYRIMIDINE NUCLEOSIDE ANALOGUES | University College Cardiff Consultants Limited (GB) | 2003-01-15 | — | — | EP | disclosed |
| WO-2001083501-A1 | ANTI-VIRAL PYRIMIDINE NUCLEOSIDE ANALOGUES | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2001-11-08 | — | — | WO | disclosed |
| EP-0409634-A2 | Liquid crystal compounds and optically active compounds | SANYO CHEMICAL INDUSTRIES LTD. (JP) | 1991-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030148967-A1 | Anti-viral pyrimidine nucleoside analogues | NUDT1, DNTT, RNMT | NR5A1 831/4885LTA4H 2687/4885TP53 936/4885 |
| US-20210198316-A9 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | MRPL21, PEPD, CTSC | NR5A1 3703/4885LTA4H 3475/4885TP53 3354/4885 |
| US-20230133667-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | MRPL21, PEPD, CTSC | NR5A1 3703/4885LTA4H 3475/4885TP53 3354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.